So, what's the deal with GIP, you might ask
That said, semaglutide remains highly effective
The last 5 years have seen the emergence of efficacious peptide-based therapies for obesity treatment that target glucagon-like peptide-1 receptor (GLP-1R), either selectively or via co-activation with related receptors, such as the glucose-dependent insulinotropic polypeptide and/or glucagon receptors 1
Does lifestyle influence metabolic research outcomes
GLP-1 RA medications such as Semaglutide (Ozempic/Wegovy), Tirzepatide (Mounjaro), etc
| 1 Youre not in a calorie deficit | 2 Youre in a weight-loss plateau | 3 Your current dose isnt high enough to promote lower hunger | Practical strategies | Frequently asked questions | Take home message The main reasons youre not losing weight on semaglutide (Wegovy/Ozempic) might be that youre not eating in a calorie deficit, youve hit a weight-loss plateau, or the current dose that youre on isnt high enough to lower your hunger to the point where youre eating less